HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

Targeted Cancer Therapies

treatment  therapy  therapies  angiogenesis  targeted  trials  7.49  antibody  apoptosis  immunotherapy  inhibitor  kinase  molecular  monoclonal  precision  Ras  signal  targets  VEGF 

A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.

Preview   0 Users liked this content.
NCI

Vaccine Therapy for Unresectable Chordoma

vaccine  malignant mesothelioma  immunotherapy  chordoma 

In this phase II clinical trial, adult patients with inoperable chordoma who are scheduled to undergo radiation therapy will be randomly assigned to receive a yeast-based vaccine that targets a protein called brachyury or a placebo injection.

Preview   0 Users liked this content.
NCI

New Therapies Are Changing the Outlook for Advanced Melanoma

melanoma  skin cancer  immunotherapy  targeted therapy  checkpoint inhibitor  PD-1  CTLA-4  BRAF  MEK  vemurafenib  dabrafenib  trametinib  ipilimumab  pembrolizumab 

An article about a host of new treatment options that have been produced in the last several years for patients with the skin cancer melanoma.

Preview   0 Users liked this content.
NCI

Biological Therapies for Cancer

cancer  treatment  vaccines  therapy  therapies  biological  immune system  immunotherapy  monoclonal  gene  interferons  interleukin-2  IL-2  antibodies  immunomodulating  7.2  bacillus Calmet-Guérin  cytokines  hematopoietic growth factors  oncolytic virus 

A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies.

Preview   0 Users liked this content.
NCI

New Therapies Are Changing the Outlook for Advanced Melanoma

melanoma  skin cancer  immunotherapy  targeted therapy  checkpoint inhibitor  PD-1  CTLA-4  BRAF  MEK  vemurafenib  dabrafenib  trametinib  ipilimumab  pembrolizumab 

An article about a host of new treatment options that have been produced in the last several years for patients with the skin cancer melanoma.

Preview   0 Users liked this content.